Patent Office Trials Blog
  • 3/28/2019

    The Internet of Things (IoT) is a network of devices including electronics and software that allow these so-called "things" to exchange data. Many titans of the tech industry are now selling IoT devices and are thus obtaining patents on such devices, preparing for potential patent wars. The rapid rise of IoT devices raises issues of indirect infringement of U.S. patents. This presentation will introduce these indirect infringement issues and provide key patent prosecution strategies to tackle the confounding issues.

    The lecture will take place on March 28th, 2019 at 12:00 PM at Sughrue's Washington, D.C. Office (6th floor). For more information, click here.

  • 3/20/2019

    Sughrue counsel, Marina Zalevsky, will join June Cohan, Senior Legal Advisor in the Office of Patent Legal Administration, to discuss 2019 Revised Guidelines on Section 101.

    "In coordination with the Hot Topics Subcommittee, we are pleased to present a behind the scenes look at the 2019 Revised Guidance on Section 101.

    Ms. June Cohan, Senior Legal Advisor in the Office of Patent Legal Administration at the USPTO will discuss the revised Guidance and provide selected USPTO examples and insights illustrating how the USPTO analyzes claims involving "laws of nature or natural phenomena," "abstract ideas," and "mental steps."

    Ms. Cohan practiced patent law for 16 years, has taught advanced patent law and intellectual property courses at Georgetown University and George Washington University. She joined the USPTO in 2013, where she specializes in patent subject matter eligibility and Section 112 issues.

    Marina Zalevsky, Chair of the AIPLA Section 101 Subcommittee, will discuss initial impressions of how Examiners have been applying the Guidance and its effect on practice.

    Presented by: June Cohan of Office of Patent Legal Administration at the USPTO; and Marina Zalevsky of Sughrue Mion PLLC."

    Register and view more information here.

  • 3/5/2019
    On March 4, 2019, the Supreme Court settled a long-standing circuit split involving the timing of when a copyright infringement action may be filed. Some circuit courts took the position that a copyright infringement action could be filed only once a copyright registration had issued. Others held that an action could be filed once a copyright application was filed with the Copyright Office.

    In Fourth Estate Public Benefit Corp. v. Wall-Street.com, the Supreme Court decided that a copyright owner must have a copyright registration before it can bring a copyright infringement action.

    The decision may be found here.

    If you have any questions about copyright matters, please contact partner Leigh Ann Lindquist.
  • 2/27/2019
    On February 27, 2019, Sughrue Mion will show a broadcast of the USPTO's virtual training on the "2019 Revised Patent Subject Matter Eligibility Guidance: Advanced Module." The virtual training corresponds to training actually provided to the USPTO Examiners. The Advanced Module is based on the recent 2019 Revised Patent Subject Matter Eligibility Guidance that revises the procedures for how examiners analyze claims under 35 U.S.C. 101. The USPTO webcast presentation will begin promptly at 1:00 PM and ends at 4:00 PM.

    Read more here.
More News
  • 4/16/2019
    Seoul,
    Korea
    Sughrue Mion will be presenting at the Korea Pharm & Bio 2019 Conference in Seoul (KINTEX), Korea April 16-18, 2019. Ms. Sunhee Lee, Mr. Michael Dzwonczyk, Mr. Raja Saliba, Mr. Grant Shackelford and Mr. Hyunseok Park from the Sughrue’s Biotechnology/Life Science and Patent Litigation Practice Groups will provide strategic insights critical to patent owners in the life science space. These talks will span considerations pertinent to building strong and versatile life science patent portfolios and also successfully monetizing them. The Attorneys from Sughrue will also discuss litigation topics relating to ANDA submissions on small molecule pharmaceuticals, as well as biosimilars, drawing from the Firm’s experience in these areas to provide guidance on practical considerations on critical aspects thereof. More information can be obtained from the conference website at https://www.koreapharm.org/kor/main.asp.